NAPROXEN SODIUM
- Product NDC
- 42291-516
- 11-digit product format
- 422910516
- Labeler code
- 42291
- Product ID
- 42291-516_d57d2ee2-b4c6-82e9-e053-2995a90a7499
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- NAPROXEN SODIUM
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- AvKARE
- Application
- ANDA078432
- Marketing category
- ANDA
- Marketing start
- 2017-10-30
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN SODIUM
- Active strength
- 275 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42291-516-01 | 42291051601 | 100 TABLET in 1 BOTTLE (42291-516-01) | 100 tablet | 2017-10-30 | 0000-00-00 | No | No | Current |